申请人:Macronex, Inc.
公开号:US05643893A1
公开(公告)日:1997-07-01
Novel N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives have been found to be useful as inhibitors of inflammatory cytokines. They can be used, inter alia, in the therapy of septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and AIDS. The compounds are typically prepared by reaction of an bromoalkyl boronic acid with the purine, indole or pyrimidine base.
新颖的N-取代-(二羟基硼基)烷基嘌呤、吲哚和嘧啶衍生物被发现可用作抑制炎症细胞因子的药物。它们可以用于治疗败血症休克、虚弱症、类风湿关节炎、炎症性肠病、多发性硬化和艾滋病等。这些化合物通常是通过溴代烷基硼酸与嘌呤、吲哚或嘧啶碱基的反应制备而成。